Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Kennedy, A. L.; Myers, K. C.; Bowman, J.; Gibson, C. J.; Camarda, N. D.; Furutani, E. M.; Muscato, G. M.; Klein, R. H.; Ballotti, K.; Liu, S.; Harris, C. E.; Galvin, A.; Malsch, M.; Dale, D.; Gansner, J. M.; Nakano, T. A.; Bertuch, A.; Vlachos, A.; Lipton, J. M.; Castillo, P.; Connelly, J.; Churpek, J.; Edwards, J. R.; Hijiya, N.; Ho, R. H.; Hofmann, I.; Huang, J. N.; Keel, S.; Lamble, A.; Lau, B. W.; Norkin, M.; Stieglitz, E.; Stock, W.; Walkovich, K.; Boettcher, S.; Brendel, C.; Fleming, M. D.; Davies, S. M.; Weller, E. A.; Bahl, C.; Carter, S. L.; Shimamura, A.; Lindsley, R. C.
Show abstract
Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with predisposition to developing leukemia. We found that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53. EIF6 mutations cause functional compensation for the germline deficiency by alleviating the SDS ribosome joining defect, improving translation, and reducing p53 activation. TP53 mutations decrease checkpoint activation without affecting ribosome assembly. We link development of leukemia with acquisition of biallelic TP53 alterations. Our results define distinct pathways of clonal selection driven by germline fitness constraint and provide a mechanistic framework for clinical surveillance.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells. 96%
- Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells 96%
- Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients 96%
Similar papers in this journal
Similar papers in this journal
- Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia 98%
- Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition 97%
- A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy 96%
Similar papers in this journal
- Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes 96%
- Hematopoietic fitness of JAK2 V617F Myeloproliferative Neoplasms is linked to clinical outcome 96%
- Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 96%
Similar papers in this journal
- Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network 96%
- AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML 96%
- Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.